2015
DOI: 10.1021/acs.organomet.5b00458
|View full text |Cite
|
Sign up to set email alerts
|

Antibacterial and Antiparasitic Activity of Manganese(I) Tricarbonyl Complexes with Ketoconazole, Miconazole, and Clotrimazole Ligands

Abstract: Five manganese(I) tricarbonyl complexes of the general formula [Mn(CO) 3 (bpy R,R )(azole)]PF 6 with R = H, COOCH 3 , and azole = ketoconazole (ktz), miconazole (mcz), and clotrimazole (ctz) were synthesized and fully charaterized, including X-ray structure analysis for the ctz compound. The antibacterial activity on a panel of eight Gram-positive and Gram-negative bacterial strains was determined. While there was no effect on the latter microorganisms, the ctz complex showed submicromolar activity on Staphylo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
59
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 79 publications
(73 citation statements)
references
References 54 publications
1
59
0
Order By: Relevance
“…In addition to ruthenium, other organometallic complexes have also been reported to display interesting antiparasitic and/or anti-infective activities (29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42). For instance, one manganese(I) tricarbonyl complex, [Mn(CO) 3 (bpy R,R )(Ctz)]PF 6 (where bpy R,R is 2,2=-bipyridine), showed submicromolar activity against Staphylococcus aureus and Staphylococcus epidermidis with MICs of 0.625 M. Moreover, the related complex [Mn(CO) 3 (bpy R,R )(Ktz)]PF 6 (where Ktz is ketoconazole) was active against Trypanosoma brucei with an IC 50 of 0.7 M, while the IC 50 for mammalian cells was more than 10 times higher (43).…”
mentioning
confidence: 99%
“…In addition to ruthenium, other organometallic complexes have also been reported to display interesting antiparasitic and/or anti-infective activities (29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42). For instance, one manganese(I) tricarbonyl complex, [Mn(CO) 3 (bpy R,R )(Ctz)]PF 6 (where bpy R,R is 2,2=-bipyridine), showed submicromolar activity against Staphylococcus aureus and Staphylococcus epidermidis with MICs of 0.625 M. Moreover, the related complex [Mn(CO) 3 (bpy R,R )(Ktz)]PF 6 (where Ktz is ketoconazole) was active against Trypanosoma brucei with an IC 50 of 0.7 M, while the IC 50 for mammalian cells was more than 10 times higher (43).…”
mentioning
confidence: 99%
“…It is evident that the tip of the iceberg has only barely been scratched when it comes to investigating the antimicrobial potential of metal complexes (Table 2). Although there have been in vitro studies into many other elements, including chromium [115], iron [116], manganese [117][118][119][120], copper [121], rhodium [122], palladium [123,124], and platinum [125], these were often preliminary in nature and require further validation [27,124,126]. While some metal complexes and metal ions have been shown to possess excellent antimicrobial activity, the question remains whether or not metals offer any significant advantages over purely organic compounds.…”
Section: Metal Complexes Vs Organic Moleculesmentioning
confidence: 99%
“…In this model, an Fe-30Mn group could be related to the effect of Mn release. Simpson et al [38] showed that coordination of Mn in tricarbonyl complexes drugs improve their biological activity. Also, another research on Mn-doped ZnO nanoparticles enhanced antibacterial activity compared to ZnO nanoparticles (NPs) [39].…”
Section: Accepted Manuscriptmentioning
confidence: 99%